INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children with Type 1 Diabetes

Overview of attention for article published in Diabetes Care, November 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 15 news outlets
twitter: 13 X users

facebook: 1 Facebook page
bluesky: 3 Bluesky users

Readers on

mendeley: 8 Mendeley

So far, Altmetric has seen 3 Bluesky posts from 3 Bluesky users, with an upper bound of 107 followers.

Inhaled technosphere insulin can be safely used in children with diabetes and is associated with greater treatment satisfaction and less weight gain than conventional injectable insulin. Read here ➡️ doi.org/10.2337/dc25-1994

Primary results from the INHALE-1 study examining inhaled insulin use in children with #T1D were published in November! diabetesjournals.org/care/article...

Inhaled technosphere insulin boosts satisfaction and limits weight gain in children with type 1 diabetes, despite noninferior HbA1c results. by Haller MJ, Kanapka L (...) Beck RW et 38 al. in Diabetes Care #MedSky 👉 get more here 📖 read the article: …

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity.